Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s What Happened

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $14.94, but opened at $14.15. Ono Pharmaceutical shares last traded at $14.15, with a volume of 200 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered shares of Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a report on Friday, September 4th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Ono Pharmaceutical has a consensus rating of “Hold”.

Ono Pharmaceutical Stock Performance

The stock’s 50-day moving average is $14.93 and its 200-day moving average is $14.64. The stock has a market cap of $6.65 billion, a price-to-earnings ratio of 13.48 and a beta of 0.33. The company has a current ratio of 3.28, a quick ratio of 2.86 and a debt-to-equity ratio of 0.08.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd. is a Japanese research-driven pharmaceutical company headquartered in Osaka. The company discovers, develops, manufactures and markets prescription medicines, with a focus on oncology, immunology, neurology and other specialty-care areas. Its activities include both internally developed products and collaborations with pharmaceutical and biotechnology companies worldwide.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used to treat multiple types of cancer.